{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:47:49Z","timestamp":1774550869079,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor characterized by aggressive local invasion and a syndrome of platelet trapping known as Kasabach-Merritt phenomenon that, through deposition of platelet derived growth factors, may perpetuate the growth of the tumor. Although many cases of KHE are successfully treated with local control or low-intensity chemotherapy, some cases are often refractory even to aggressive treatment. Herein, we describe a patient with a refractory, recurrent KHE despite multiple attempts at local control and intensive chemotherapy, that ultimately was successfully treated with rationally designed and low-intensity combination therapy of sirolimus and aspirin.<\/jats:p>","DOI":"10.1097\/mph.0000000000001046","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T19:58:55Z","timestamp":1513108735000},"page":"e239-e242","source":"Crossref","is-referenced-by-count":16,"title":["Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin"],"prefix":"10.1097","volume":"40","author":[{"given":"Suzanne P.","family":"MacFarland","sequence":"first","affiliation":[{"name":"Division of Hematology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Missisippi Medical Center, Jackson, MS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa J.","family":"States","sequence":"additional","affiliation":[{"name":"Division of Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Charles","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Oncology, The Children's Hospital of Philadelphia"},{"name":"Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi J.","family":"Balamuth","sequence":"additional","affiliation":[{"name":"Division of Oncology, The Children's Hospital of Philadelphia"},{"name":"Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B.","family":"Womer","sequence":"additional","affiliation":[{"name":"Division of Oncology, The Children's Hospital of Philadelphia"},{"name":"Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy S.","family":"Olson","sequence":"additional","affiliation":[{"name":"Division of Hematology"},{"name":"Division of Oncology, The Children's Hospital of Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00000478-199304000-00001","article-title":"Kaposiform Hemangioendothelioma of infancy and childhood","volume":"17","author":"Zukerberg","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2012.06.044","article-title":"Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals","volume":"162","author":"Croteau","year":"2013","journal-title":"J Pediatr"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/bjh.13557","article-title":"Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon","volume":"171","author":"O'Rafferty","year":"2015","journal-title":"Br J Haematol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00043426-199811000-00012","article-title":"Kasaback-Merritt Syndrome-associated kaposiform hemangioendothelioma successfully treated with cyclophosphamide, vincristine, and actinomycin D","volume":"20","author":"Hu","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/pbc.20750","article-title":"Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen","volume":"49","author":"Hauer","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/pbc.22766","article-title":"Treatment of childhood kaposiform hemangioendothelioma with sirolimus","volume":"55","author":"Blatt","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0032-1323823","article-title":"Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus","volume":"224","author":"Jahnel","year":"2012","journal-title":"Klin Padiatr"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/pbc.24543","article-title":"Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon","volume":"60","author":"Fernandez-Pineda","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00432-013-1549-3","article-title":"Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma","volume":"140","author":"Kai","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clinimag.2015.01.003","article-title":"Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms","volume":"39","author":"Iacobas","year":"2015","journal-title":"Clin Imaging"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/pbc.25241","article-title":"Successful treatment of Kaposiform hemangioendothelioma with everolimus","volume":"62","author":"Uno","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00431-015-2572-y","article-title":"Sirolimus for the treatment of children with various complicated vascular anomalies","volume":"174","author":"Lackner","year":"2015","journal-title":"Eur J Pediatr"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-06-3341","article-title":"Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression","volume":"67","author":"Phung","year":"2007","journal-title":"Cancer Res"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/ATVBAHA.109.185918","article-title":"Rapamycin inhibition of the Akt\/mTOR pathway blocks select stages of VEGF-A164-driven angiogenesis, in part by blocking S6Kinase","volume":"29","author":"Xue","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/modpathol.3800444","article-title":"D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma","volume":"18","author":"Debelenko","year":"2005","journal-title":"Mod Pathol"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/pbc.25422","article-title":"Successful treatment of kaposiform lymphangiomatosis with sirolimus","volume":"62","author":"Wang","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1177\/0003489415583330","article-title":"Successful treatment of macroglossia due to lymphatic malformation with sirolimus","volume":"124","author":"Yesil","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3476(83)80550-2","article-title":"Use of aspirin and dipyridamole in children with platelet trapping syndromes","volume":"102","author":"Koerper","year":"1983","journal-title":"J Pediatr"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201805000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:33:08Z","timestamp":1695011588000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201805000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001046","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}